Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-β protein

被引:405
|
作者
Harper, JD
Lieber, CM
Lansbury, PT
机构
[1] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA
[2] MIT, Dept Chem, Cambridge, MA 02139 USA
[3] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA 02115 USA
来源
CHEMISTRY & BIOLOGY | 1997年 / 4卷 / 12期
关键词
Alzheimer's disease; amyloid; atomic force microscopy; nucleation; protofibril seeding;
D O I
10.1016/S1074-5521(97)90303-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Amyloid plaques composed of the fibrillar form of the amyloid-beta protein (A beta) are the defining neuropathological feature of Alzheimer's disease (AD). A detailed understanding of the time course of amyloid formation could define steps in disease progression and provide targets for therapeutic intervention. Amyloid fibrils, indistinguishable from those derived from an AD brain, can be produced in vitro using a seeded polymerization mechanism. In its simplest form, this mechanism involves a cooperative transition from monomeric A beta to the amyloid fibril without the buildup of intermediates. Recently, however, a transient species, the A beta amyloid protofibril, has been identified. Here, we report studies of A beta amyloid protofibril and its seeded transition into amyloid fibrils using atomic force microscopy. Results: Seeding of the protofibril-to-fibril transition was observed. Preformed fibrils, but not protofibrils, effectively seeded this transition. The assembly state of A beta influenced the rate of seeded growth, indicating that protofibrils are fibril assembly precursors, The handedness of the helical surface morphology of fibrils depended on the chirality of A beta, Finally, branched and partially wound fibrils were observed. Conclusions: The temporal evolution of morphologies suggests that the protofibril-to-fibril transition is nucleation-dependent and that protofibril winding is involved in that transition. Fibril unwinding and branching may be essential for the post-nucleation growth process. The protofibrillar assembly intermediate is a potential target for AD therapeutics aimed at inhibiting amyloid formation and AD diagnostics aimed at detecting presymptomatic disease.
引用
收藏
页码:951 / 959
页数:9
相关论文
共 50 条
  • [1] Atomic force microscopy to study molecular mechanisms of amyloid fibril formation and toxicity in Alzheimer's disease
    Drolle, Elizabeth
    Hane, Francis
    Lee, Brenda
    Leonenko, Zoya
    DRUG METABOLISM REVIEWS, 2014, 46 (02) : 207 - 223
  • [2] Structural Diversity of Alzheimer's Disease Amyloid-β Dimers and Their Role in Oligomerization and Fibril Formation
    Tsigelny, Igor F.
    Sharikov, Yuriy
    Kouznetsova, Valentina L.
    Greenberg, Jerry P.
    Wrasidlo, Wolfgang
    Gonzalez, Tania
    Desplats, Paula
    Michael, Sarah E.
    Trejo-Morales, Margarita
    Overk, Cassia R.
    Masliah, Eliezer
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 39 (03) : 583 - 600
  • [3] New class of inhibitors of amyloid-β fibril formation -: Implications for the mechanism of pathogenesis in Alzheimer's disease
    Lashuel, HA
    Hartley, DM
    Balakhaneh, D
    Aggarwal, A
    Teichberg, S
    Callaway, DJE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (45) : 42881 - 42890
  • [4] Modulation of β-Amyloid Fibril Formation in Alzheimer's Disease by Microglia and Infection
    Brown, Madeleine R.
    Radford, Sheena E.
    Hewitt, Eric W.
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2020, 13
  • [5] Molecular mechanisms initiating amyloid β-fibril formation in Alzheimer's disease
    Kirkitadze, MD
    Kowalska, A
    ACTA BIOCHIMICA POLONICA, 2005, 52 (02) : 417 - 423
  • [6] Amyloid β-Protein Assembly and Alzheimer's Disease: Dodecamers of Aβ42, but Not of Aβ40, Seed Fibril Formation
    Economou, Nicholas J.
    Giammona, Maxwell J.
    Do, Thanh D.
    Zheng, Xueyun
    Teplow, David B.
    Buratto, Steven K.
    Bowers, Michael T.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2016, 138 (06) : 1772 - 1775
  • [7] Analysis of fibril formation of amyloid-β-protein by stretched exponential function
    Shinozaki, K
    Konakahara, T
    Okuno, H
    Kodaka, M
    PROTEIN AND PEPTIDE LETTERS, 2003, 10 (06): : 569 - 574
  • [8] Amyloid fibril toxicity in Alzheimer's disease and diabetes
    Lorenzo, A
    Yankner, BA
    NEUROBIOLOGY OF ALZHEIMER'S DISEASE, 1996, 777 : 89 - 95
  • [9] The role of lipid membrane in amyloid fibril formation and toxicity in Alzheimer's disease
    Drolle, E.
    Hane, F.
    Choi, Y.
    Attwood, S.
    Ollagnier, A.
    Finot, E.
    Leonenko, Z.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2013, 42 : S120 - S120
  • [10] Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-β peptide
    Cottingham, MG
    Hollinshead, MS
    Vaux, DJT
    BIOCHEMISTRY, 2002, 41 (46) : 13539 - 13547